Uncategorized Where Does The Future Lies In The Chinese CAR-T Market?

Where Does The Future Lies In The Chinese CAR-T Market?

In 2017, a series of events have drawn national and international attentions to CAR-T therapy, making it one of the hottest topic of the year. In January, Shanghai Fosun and Kite Pharma has formed a joint venture, with each holding 50% stake. In February, Juno has announced to discontinue its JCAR015 trail and began to …

Read Article Read More

Uncategorized The 4 Trends of In Vitro Diagnostics in China

The 4 Trends of In Vitro Diagnostics in China

In recent years, merger and acquisition (M&A) has been the dominant theme in the Chinese healthcare and pharmaceutical industry, especially in the field of in vitro diagnostics (IVD). A number of companies have undergone acquisitions and this trend will continue to grow in 2018. This integration phenomenon has raised new requirements and challenges for large customer-oriented central …

Read Article Read More